CFLAR and cancer: Since c-FLIP(L) prevents death receptor-mediated apoptosis, we then examined whether its inhibition could increase the sensitivity of cancer cells to TRAIL, since it was reported that targeting c-FLIP directly or indirectly could overcome apoptosis resistance [36,37].